Rare Disease Report

Neurology

Stay up-to-date on the latest rare disease news by reading the top 5 articles of the week.
In a recent interview with Rare Disease Report®, Hartmann Wellhoefer, MD, discussed the biggest challenges faced and advances being made in the fight against MPS.
 
The FDA has granted an orphan drug designation to Q Therapeutics Inc.’s Q-Cell for the treatment of transverse myelitis.
Stay up-to-date on the latest rare disease news by reading the top 5 articles of the week.
Fingolimod has been linked with a lower rate of relapse and less accumulation of lesions on MRI over a 2-year period compared with interferon beta-1a in a phase 3 PARADIGMS trial. 
Cure CMD (Congenital Muscular Dystrophy) is pleased to announce the recipient of a grant co-funded with Muscular Dystrophy UK: Dr. Giséle Bonne at the INSERM-Myology Institute in Paris.
Stay up-to-date on the latest rare disease news by checking out our top 5 articles of the week.
The FDA has denied accelerated approval for Pompe disease treatment, AT-GAA. However, plans for a pivotal study are still underway, so approval could be forthcoming.
 
There’s no cure for Huntington’s disease, but a new study by investigators in Sweden is exploring potential new approaches to treating the neurodegenerative disease.
 
Stay up-to-date on the latest rare disease news by checking out our top 5 articles of the week.
Copyright © RareDR 2013-2019 Rare Disease Communications. All Rights Reserved.